News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Hanger Inc. (Formerly known as Hanger Orthopedic Group, Inc.) Reports Third Quarter 2013 Results
October 30, 2013
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
AUSTIN, Texas, Oct. 29, 2013 /PRNewswire/ --
•Adjusted diluted EPS of $0.62, a 24% increase
•Diluted EPS of $0.61
•Net sales increase of 11.8%
Help employers find you! Check out all the
jobs
and
post your resume
.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
FDA
Novo’s canned heart disease trials, Novartis’ clinical fails, first approval for Alexander disease
September 9, 2026
·
1 min read
·
Jef Akst
IPO
2026 IPO stock tracker: How newly public biotechs are performing
September 9, 2026
·
1 min read
·
Gabrielle Masson
Venture capital
Solstice rises with $225M to develop next-gen CTLA-4 drug from China
September 9, 2026
·
2 min read
·
Annalee Armstrong
Funding
Caspian launches with $50M, Lilly support to advance disease-modifying diabetes bet
September 9, 2026
·
2 min read
·
Tristan Manalac